← ANALYST RATINGS · TIPRANKS
Radnet (RDNT): analyst forecast and price target
Analyst consensus
Strong Buy4 Buy0 Hold0 Sell
Ratings of 4 analysts in the last 3 months12-month forecast
Based on 4 price targets given in the last 3 months, the average target is $91.00, the highest $96.00, the lowest $79.00. The average is +32.3% from the last price of $68.80.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Diagnostics and ResearchxAI Grok-3 | TipRanks - xAI | $73.00 → $72.00−1.4% | Hold | +4.7% | Reiterated | 11.10.26on TipRanks Oct 10 23:05 | — | |
| AI Google Medical - Diagnostics and ResearchGemini 3-pro | TipRanks - Google | $74.00 → $73.00−1.4% | Hold | +6.1% | Downgrade | 11.10.26on TipRanks Oct 10 23:05 | — | |
| AI DeepSeek Medical - Diagnostics and ResearchDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $72.00 → $73.00+1.4% | Hold | +6.1% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI OpenAI Medical - Diagnostics and ResearchOpenAI 5.2 | TipRanks - OpenAI | $73.00 → $74.00+1.4% | Hold | +7.6% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI Anthropic Medical - Diagnostics and ResearchAnthropic Opus-4.5 | TipRanks - Anthropic | $69.00 → $70.00+1.4% | Hold | +1.7% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| AI PerPlexity Medical - Diagnostics and ResearchPerPlexity SonarPro | TipRanks - PerPlexity | $70.00 → $71.00+1.4% | Hold | +3.2% | Reiterated | 09.10.26on TipRanks Oct 8 23:05 | — | |
| John Ransom★★★★★★★★★★#681 · hits 60% · avg +10.2% | Raymond James | $95.00 | Buy | +38.1% | Reiterated | 28.09.26on TipRanks 09:05 | +2.2%next day −1.4% · 5 days −2.9% | ↗ |
| David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% | Truist Financial | $94.00 | Buy | +36.6% | Reiterated | 22.09.26on TipRanks 08:10 | +1.7%next day −0.3% · 5 days −3.2% | ↗ |
| Brian Tanquilut★★★★★★★★★★#1681 · hits 52% · avg +6.6% | Jefferies | $95.00 → $96.00+1.1% | Buy | +39.5% | Reiterated | 17.09.26on TipRanks 09:26 | +1.5%next day −2.4% · 5 days −9.2% | ↗ |
| Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% | Barclays | $65.00 → $79.00+21.5% | Buy | +14.8% | Reiterated | 28.08.26on TipRanks 04:25 | −0.8%next day +1.9% · 5 days −1.3% | ↗ |
| Yuan Zhi★★★★★★★★★★#1180 · hits 41% · avg +20.7% | B. Riley Securities | $87.00 → $83.00−4.6% | Buy | +20.6% | Assigned | 01.05.26on TipRanks 09:30 | +0.3%next day +2.8% · 5 days 0.0% | ↗ |
| Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% | KeyBanc | $92.00 | Buy | +33.7% | Reiterated | 29.04.26on TipRanks 04:15 | −3.4%next day +0.2% · 5 days +1.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Radnet
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $91.00 at a price of $68.94 (+32.0%); now: $91.00 at $68.80 (+32.3%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 0 | 0 | 0 |
| Buy | 10 | 5 | 5 | 4 | 7 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Best top-analyst consensus in the sector · Healthcare
About Radnet
- CEO: Howard G. Berger
- Employees: 9,060
- 1508, 1510 and 1516 Cotner Avenue, Los Angeles, CA, 90025, US
- www.radnet.com
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Data from the stock’s TipRanks forecast page, read 101 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗